Stevanato Group S.p.A. (NYSE:STVN) Shares Acquired by Peregrine Capital Management LLC

Peregrine Capital Management LLC boosted its position in Stevanato Group S.p.A. (NYSE:STVN) by 1.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 366,078 shares of the company’s stock after buying an additional 6,661 shares during the quarter. Peregrine Capital Management LLC’s holdings in Stevanato Group were worth $7,977,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Thrivent Financial for Lutherans boosted its holdings in shares of Stevanato Group by 67.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after buying an additional 1,123,104 shares during the period. Jennison Associates LLC bought a new position in Stevanato Group in the fourth quarter worth about $20,239,000. Pembroke Management LTD lifted its holdings in Stevanato Group by 143.7% in the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock worth $21,023,000 after acquiring an additional 619,747 shares during the last quarter. Conestoga Capital Advisors LLC boosted its stake in Stevanato Group by 5.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock valued at $176,128,000 after acquiring an additional 407,086 shares during the period. Finally, Fred Alger Management LLC grew its holdings in shares of Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after purchasing an additional 208,830 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on STVN. Wolfe Research started coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 price objective for the company. Bank of America increased their price target on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Finally, Morgan Stanley restated an “equal weight” rating and set a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Stevanato Group has a consensus rating of “Moderate Buy” and an average target price of €28.60 ($29.79).

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €20.20 ($21.04) on Wednesday. The business has a fifty day simple moving average of €21.89 and a 200 day simple moving average of €20.53. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.25) and a 1 year high of €34.00 ($35.42). The firm has a market cap of $6.12 billion, a price-to-earnings ratio of 42.98, a P/E/G ratio of 6.86 and a beta of 0.56.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.